Pyoderma Withdrawn Phase 4 Trials for Sisomicin (DB12604)

Also known as: Dermatitis pyogenic / Dermatitis gangrenosa / Pyoderma (skin infection)

IndicationStatusPhase
DBCOND0014093 (Pyoderma)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00202891Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)Treatment